New study shows tirzepatide reduces LV mass and heart fat in obesity-related HFpEF, potentially improving heart failure outcomes.
7don MSN
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
GLP-1RAs have shown considerable effects for weight loss to treat obesity. A recent Phase 3 trial published in Nature Medicine found that tirzepatide led to additional weight loss of over 20% when ...
The newest weight-loss drugs ... of health effects. The study included people taking different types drugs in this category—semaglutide (Wegovy and Ozempic), and tirzepatide (Mounjaro and ...
USA TODAY on MSN17d
Here's why researchers think most people stop taking weight loss drugs within a yearNearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results